CIPO trademark

TWIIST

FiledCIPOWord markClass 5Class 9Class 10Class 35+3

"TWIIST" is a word mark owned by DEKA Research & Development Corp., filed at the CIPO on September 8, 2026. It is filed and waiting for examination and covers classes 5, 9, 10, 35, 41, 42 and 44.

View DEKA Research & Development Corp. portfolioGet this data via the API
Official CIPO record
TWIIST
Word mark as filed with the CIPO
Status
Filed
Since September 8, 2026
Filed
September 8, 2026
Registered
Not yet
Expires
Not recorded
Application no.
2499602
Registration no.
Not yet
Office
CIPO
Canadian Intellectual Property Office
Mark type
Word mark
7 classes
Ownership

Who owns TWIIST

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

DEKA Research & Development Corp.

United States

83 trademarks in the portfolioView company

Representative

Gowling WLG (Canada) LLP

Gowling WLG (Canada) LLP

Goods and services

What the mark covers

The products and services TWIIST is filed for, grouped by Nice class.

  • Cartridges sold pre-filled with medication for medical use in the field of diabetes, hypoglycemia and hypertension; adhesive overlays in the nature of adhesive medical tape, bandages

  • Downloadable software as a medical device (SaMD) for predicting analyte levels and adjusting infusion pump settings based on personalized data; downloadable mobile applications that allow users to access and browse information and education on managing, treating, and living with chronic disease; 9V batteries; AA batteries; AAA batteries; alkaline batteries; C-cell batteries; D-cell batteries; rechargeable alkaline batteries; solar batteries; solar-powered rechargeable batteries; solar-powered battery chargers; chargers for general purpose batteries; lithium-ion battery chargers

  • Medical devices, namely, infusion and injection devices for administering drugs and measured amounts of solutions into the bloodstream over time; apparatus for monitoring blood analyte levels; wearable subcutaneous drug delivery devices, sold empty in the nature of injectors; injectors for medical purposes, worn on the body; chronic disease management devices, in the nature of medical sensors that are implanted or inserted into the human body used to continuously monitor the concentration of analytes in the human body and accessories therefor, namely, receivers, sensor housings and sensor insertion devices; medical infusion sets comprised of infusion tubing, infusion needles, needle guards, connectors, attachment clips, and accessories therefor; pouches and mounts for use with infusion pumps

  • Administration of a trade-in and upgrade program for drug delivery and chronic disease management devices; mail order, online and telephone pharmacy retail services featuring chronic disease management supplies medications, drugs and other prescriptions

  • Educational services, namely, creating and developing web-based and in person classes, seminars, workshops and programs in the field of managing and living with chronic disease; personalized training and coaching in the use of monitoring devices and infusion pumps in the treatment of chronic disease; training of healthcare providers in chronic disease treatment and the use of infusion pumps and infusion sets

  • Software-as-a-service (SaaS) featuring software for use in the acquisition, capture, processing, presentation, transmission and storage of medical and physiological data obtained from medical sensors that are implanted or inserted into the human body; hosting an interactive web site featuring technology that enables users to enter, access, track, monitor and generate health and medical information and reports relating to managing chronic disease, medication and analyte levels

  • Interactive medical monitoring, reporting and alert services for infusion pump users for monitoring and managing chronic disease; providing medical information related to chronic diseases, including advice on treatment options and chronic disease management by means of a web site; providing medical information in the form of advice on treatment and management of chronic diseases, namely, diabetes, hypoglycemia and hypertension for consumers and healthcare practitioners by means of online databases; medical consultation services, namely, patient ambassador program to communicate medical information to people with chronic disease

History

What has happened so far

Steps recorded by the CIPO, newest first.

  1. Formalized
  2. Created
  3. Filed
FAQ

About TWIIST

Who owns the trademark "TWIIST"?

The CIPO trademark "TWIIST" (application 2499602) is owned by DEKA Research & Development Corp.

What is the status of "TWIIST"?

Its status at the CIPO is: filed.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull TWIIST and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_01a08761-41b0-76bd-a38c-54b09937c0ea
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_01a08761-41b0-76bd-a38c-54b09937c0ea",
  "object": "trademark",
  "mark_text": "TWIIST",
  "status": {
    "primary": "pending",
    "stage": "filed"
  },
  "office_code": "CA",
  "application_number": "2499602",
  "filing_date": "2026-09-08",
  "nice_classes": [
    5,
    9,
    10,
    35,
    41,
    42,
    44
  ],
  "owners": [
    {
      "name": "DEKA Research & Development Corp.",
      "entity_id": "ent_019ebbee-2374-77ab-b181-1979a1746fe9"
    }
  ]
}